These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21443419)

  • 41. Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation.
    Greco A; Zannetti A; Pappatà S; Albanese S; Coda AR; Ragucci M; Nardelli A; Brunetti A; Cuocolo A; Salvatore M
    Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):112-117. PubMed ID: 26329495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Change of dopamine transporter activity (DAT) during the action of bupropion (in depression)].
    Szabó Z; Argyelán M; Kanyó B; Pávics L; Janka Z
    Neuropsychopharmacol Hung; 2004 Jun; 6(2):79-81. PubMed ID: 15787205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
    Berding G; Brücke T; Odin P; Brooks DJ; Kolbe H; Gielow P; Harke H; Knoop BO; Dengler R; Knapp WH
    Nuklearmedizin; 2003 Feb; 42(1):31-8. PubMed ID: 12601452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between subjective effects of cocaine and dopamine transporter occupancy.
    Volkow ND; Wang GJ; Fischman MW; Foltin RW; Fowler JS; Abumrad NN; Vitkun S; Logan J; Gatley SJ; Pappas N; Hitzemann R; Shea CE
    Nature; 1997 Apr; 386(6627):827-30. PubMed ID: 9126740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of striatal dopamine transporter function in rats by in vivo beta-[123I]CIT pinhole SPECT.
    Scherfler C; Donnemiller E; Schocke M; Dierkes K; Decristoforo C; Oberladstätter M; Kolbitsch C; Zschiegner F; Riccabona G; Poewe W; Wenning G
    Neuroimage; 2002 Sep; 17(1):128-41. PubMed ID: 12482072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pretreatment with haloperidol reduces (123)I-FP-CIT binding to the dopamine transporter in the rat striatum: an in vivo imaging study with a dedicated small-animal SPECT camera.
    Nikolaus S; Antke C; Kley K; Beu M; Wirrwar A; Müller HW
    J Nucl Med; 2009 Jul; 50(7):1147-52. PubMed ID: 19525450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Occupancy of dopamine D2 receptors in the mouse brain measured using ultra-high-resolution single-photon emission tomography and [123]IBF.
    Acton PD; Hou C; Kung MP; Plössl K; Keeney CL; Kung HF
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1507-15. PubMed ID: 12537007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates.
    Varrone A; Stepanov V; Nakao R; Tóth M; Gulyás B; Emond P; Deloye JB; Vercouillie J; Stabin MG; Jonsson C; Guilloteau D; Halldin C
    J Nucl Med; 2011 Aug; 52(8):1313-21. PubMed ID: 21764797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Test-retest reproducibility of extrastriatal binding with
    Matsuoka K; Yasuno F; Shinkai T; Miyasaka T; Takahashi M; Kiuchi K; Kosaka J; Inoue M; Kichikawa K; Hasegawa M; Kishimoto T
    Psychiatry Res Neuroimaging; 2016 Dec; 258():10-15. PubMed ID: 27814458
    [No Abstract]   [Full Text] [Related]  

  • 50. Synthesis and radiopharmacological characterization of 2beta-carbo-2'-[18F]fluoroethoxy-3beta-(4-bromo-phenyl)tropane ([18F]MCL-322) as a PET radiotracer for imaging the dopamine transporter (DAT).
    Wuest F; Berndt M; Strobel K; van den Hoff J; Peng X; Neumeyer JL; Bergmann R
    Bioorg Med Chem; 2007 Jul; 15(13):4511-9. PubMed ID: 17467995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantification and discriminative power of
    Delva A; Van Weehaeghe D; van Aalst J; Ceccarini J; Koole M; Baete K; Nuyts J; Vandenberghe W; Van Laere K
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1913-1926. PubMed ID: 31776633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new model for separation between brain dopamine and serotonin transporters in 123I-beta-CIT SPECT measurements: normal values and sex and age dependence.
    Ryding E; Lindström M; Brådvik B; Grabowski M; Bosson P; Träskman-Bendz L; Rosén I
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1114-8. PubMed ID: 15014902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo.
    Minuzzi L; Olsen AK; Bender D; Arnfred S; Grant R; Danielsen EH; Cumming P
    Synapse; 2006 Mar; 59(4):211-9. PubMed ID: 16385509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.
    Kasper S; Tauscher J; Willeit M; Stamenkovic M; Neumeister A; Küfferle B; Barnas C; Stastny J; Praschak-Rieder N; Pezawas L; de Zwaan M; Quiner S; Pirker W; Asenbaum S; Podreka I; Brücke T
    World J Biol Psychiatry; 2002 Jul; 3(3):133-46. PubMed ID: 12478878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential alteration of the nigrostriatal dopaminergic system in Wilson's disease investigated with [123I]ss-CIT and high-resolution SPET.
    Barthel H; Sorger D; Kühn HJ; Wagner A; Kluge R; Hermann W
    Eur J Nucl Med; 2001 Nov; 28(11):1656-63. PubMed ID: 11702107
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ex vivo evaluation of N-(3-[18F]fluoropropyl)-2 beta-carbomethoxy-3 beta-(4-fluorophenyl)nortropane in rats.
    Koivula T; Marjamäki P; Haaparanta M; Fagerholm V; Grönroos T; Lipponen T; Perhola O; Vepsäläinen J; Solin O
    Nucl Med Biol; 2008 Feb; 35(2):177-83. PubMed ID: 18312827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.
    Chung SJ; Lee YH; Yoo HS; Sohn YH; Ye BS; Cha J; Lee PH
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1652-1660. PubMed ID: 30980099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PET.
    Catafau AM; Suarez M; Bullich S; Llop J; Nucci G; Gunn RN; Brittain C; Laruelle M;
    Neuroimage; 2009 Jun; 46(2):447-58. PubMed ID: 19233294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between psychostimulant-induced "high" and dopamine transporter occupancy.
    Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Ding YS; Logan J; Dewey SL; Hitzemann R; Lieberman J
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10388-92. PubMed ID: 8816810
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.